Fall in Degussa's pharmaceutical first half sales:
This article was originally published in Clinica
Executive Summary
Sales at Degussa's pharmaceuticals division, which includes amalgam manufacturer Degussa Dental, fell 1% to DM 1,073 million ($700 million) in the first half of fiscal 1996 (ended March 31st). The German group's sales decreased 5% to DM 6,900 million, while pre-tax income rose 2% to DM 186 million. The company says the weak domestic economic climate contributed to the falling sales.